elamipretide - MitoAction

Expert Series: The Road Ahead: Navigating the FDA Update on Elamipretide for Barth syndrome

Join MitoAction CEO, Kira Mann, Barth Syndrome Foundation CEO, Emily Milligan, and Stealth BioTherapeutics CEO, Reenie …